National Association of Testing Authorities, Australia
Scope of Accreditation
NSW Health Pathology
Site
NSW Health Pathology John Hunter Hospital Laboratory
Accreditation No.
3561
Site No.
3554
Date of Accreditation
28 Jun 1989
Address
Level 3 Main Building, John Hunter Hospital , 2 Lookout Road
New Lambton Heights, NSW 2305
Australia
Contact
Assoc Prof Huy Tran P: +61 (02) 49214444
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Birthing Suite
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Division of Anatomical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical tissue; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Vaginal smears; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Anus smears; Lip smears; Mouth smears; Nipple discharge; Skin smears | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix | Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material |
| Self-collected vaginal swabs | Human papilloma virus (HPV) | |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Detection of antigenic targets - Various | ||
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
Division of Clinical Chemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Serum | Ethanol |
| Caffeine | ||
| Urine | Ethanol | |
| Amphetamines; Benzodiazepines; Cannabis; Cocaine; Opiates | ||
| Buprenorphine; Methadone | ||
| Chemical pathology - Biogenic amines | Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Catecholamines; Dopamine; Homovanillic acid (HVA); Noradrenaline; Vanillylmandelic acid (VMA) |
| Metanephrine; Normetanephrine | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Tacrolimus |
| Plasma | Mycophenolate | |
| Serum | Amikacin; Carbamazepine; Digoxin; Lithium; Methotrexate; Paracetamol (acetaminophen); Phenobarbitone; Phenytoin (dilantin); Salicylate; Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | |
| Gentamicin (cidomycin, septopal, genticyn, garamycin) | ||
| Clozapine; Clozapine metabolite; Flecainide; Mexiletine; Norclozapine | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Amniotic fluid | α-Fetoprotein (AFP) |
| Faeces | CA125 antigen (CA125) | |
| Peritoneal fluid | α-Fetoprotein (AFP) | |
| Serum | β2-Microglobulin (B2M) | |
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free; α-Fetoprotein (AFP) | ||
| Urine | β2-Microglobulin (B2M) | |
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Parathyroid washing | Parathyroid hormone (PTH) |
| Plasma | Adrenocorticotropic hormone (ACTH); Renin | |
| Plasma; Serum | Insulin | |
| Saliva | Cortisol | |
| Serum | 17α-Hydroxyprogesterone; Androstenedione | |
| Aldosterone; Growth hormone; Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| C-peptide; Cortisol; Dehydroepiandrosterone (DHEA); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Procalcitonin; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone; Testosterone - Free; Testosterone - Total | ||
| Urine | Cortisol | |
| Aldosterone | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Glycated haemoglobin (HbA1c) | ||
| Serum | Fructosamine | |
| Chemical pathology - Dynamic tests | Sweat | Sweat chloride |
| Chemical pathology - Further investigation of cardiac function | Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin I |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | Lipoprotein a |
| Serum | Apolipoprotein A; Apolipoprotein B; HDL - Quantitation; Lipoprotein subclasses | |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | α1-Antitrypsin |
| Prealbumin | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Plasma; Serum | Haptoglobins | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Ammonia; Chloride; Glucose; Lactate; Lactate dehydrogenase (LDH); Protein - Total |
| Dialysates | Albumin; Bicarbonate; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Drainage fluid | Albumin; Amylase; Bilirubin - Total; Cholesterol - Total; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides; Urea; Uric acid | |
| Drainage fluid; Faeces; Peritoneal fluid; Pleural fluid; Urine | pH | |
| Drainage fluid; Faeces; Peritoneal fluid; Pleural fluid; Vitreous humor | Osmolality | |
| Faeces | Chloride; Magnesium; Phosphate; Potassium; Sodium | |
| Peritoneal fluid | Albumin; Amylase; Bilirubin - Total; Cholesterol - Total; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides; Urea; Uric acid | |
| Plasma | Osmolality | |
| Cholinesterase | ||
| Pleural fluid | Albumin; Amylase; Bilirubin - Total; Cholesterol - Total; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides; Urea; Uric acid | |
| Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; High sensitivity C-reactive protein (CRP); Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Angiotensin converting enzyme (ACE) | ||
| Synovial fluid | Albumin; Glucose; Lactate; Lactate dehydrogenase (LDH); Protein - Total | |
| Urine | Osmolality | |
| Ammonia; Amylase; Bicarbonate; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphorus; Potassium; Protein - Total; Sodium; Urea; Uric acid | ||
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | α-Fetoprotein (AFP) |
| Chemical pathology - Iron studies | Serum | Iron; Transferrin |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Blood | Homocysteine |
| Serum | β-Hydroxybutyrate | |
| Urine | Oxalate | |
| Citrate | ||
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Serum | Retinol (vitamin A); Tocopherol (vitamin E) |
| 25-Hydroxyvitamin D; Cobalamin (vitamin B12); Holotranscobalamin (active vitamin B12) | ||
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Serum | Human chorionic gonadotropin (hCG) |
| Urine | Human chorionic gonadotropin (hCG) |
Division of Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean corpuscular volume (MCV); Mean platelet volume (MPV); Morphology; Nucleated red blood cells (NRBC); Platelet count; Reticulocytes |
| Morphology | ||
| Morphology | ||
| Cerebrospinal fluid (CSF) | Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC) | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| ASPtest; Adenosine diphosphate (ADPtest); TRAPtest | ||
| Plasma | Activated partial thromboplastin time (APTT); Activated partial thromboplastin time heparin resistant (aPTT-HR); Activated protein C (APC) resistance; Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Fondaparinux; Anti-Xa - Orgaran; Anti-Xa - Rivaroxaban; Anti-Xa activity - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin; Anti-thrombin III; D-dimer; Danaparoid sodium; Emicizumab levels; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Mixing studies - APTT; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT) | |
| Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Heparin activity; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | ||
| ADAMTS-13 activity; ADAMTS-13 inhibitor; Heparin induced thrombotic thrombocytopenia (HITT) | ||
| Platelet aggregation | ||
| Haematology - Investigation of haemolysis | Urine | Haemosiderin |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Erythrocyte (RBC) sedimentation rate (ESR) | ||
| Immunohaematology - Blood group antibody detection | Blood | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Antibody titration | ||
| Blood; Serum | Antibody absorption; Other blood group antibodies; Red blood cell phenotyping; Rh | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Contamination - Microbiological |
| Blood; Plasma | Antibodies | |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Malaria | ||
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Serum | Infectious mononucleosis |
Division of Immunology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Serum | C1 esterase inhibitor |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH); Haemoglobin A (HbA) - Quantitation; Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Bone marrow; Cerebrospinal fluid (CSF); Fresh tissue; Lavage; Serous fluid | CD10; CD103; CD117; CD11b; CD123; CD13; CD138; CD14; CD16; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD25; CD27; CD3; CD303; CD33; CD34; CD38; CD4; CD43; CD45; CD46; CD5; CD52; CD56; CD57; CD66; CD7; CD8; CD81; FMC7; HLA-DR antigen; Immunoglobulin D (IgD); Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; Nuclear terminal deoxynucleotidyl transferase (NuTdT); T-cell receptor β (TCRb); T-cell receptor γδ (TCRgd); cCD22; cCD3; cCD79a; cMPO; cyKappa; cyLambda |
| Blood | Anti-D; CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD157; CD16; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD235a; CD25; CD27; CD3; CD33; CD34; CD38; CD4; CD42b; CD43; CD45; CD45RA; CD46; CD5; CD52; CD56; CD57; CD59; CD64; CD66; CD7; CD79a; CD8; CD81; Cytoplasmic CD3 (cyCD3); FMC7; Fluorescein-labelled proaerolysin (FLAER); HLA-B27; HLA-DR antigen; Haemoglobin F (HbF); Immunoglobulin D (IgD); Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; Nuclear terminal deoxynucleotidyl transferase (NuTdT); Paroxysmal nocturnal haemoglobinuria (PNH) surface markers; T-cell receptor β (TCRb); T-cell receptor γδ (TCRgd); cCD22; cMPO; cyKappa; cyLambda | |
| Immunopathology - Complete HLA antigen tissue typing | Blood | HLA-DQ class II typing |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-double stranded DNA antibodies (dsDNA) |
| Anti-RNA polymerase III antibodies (ARA, RNAP); Anti-double stranded DNA antibodies (dsDNA); Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-cardiolipin antibodies (ACA); Anti-deamidated gliadin antibodies; Anti-glomerular basement membrane antibodies (anti-GBM); Anti-intrinsic factor antibodies (IF); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Anti-adrenal cortex antibodies; Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-nuclear antibodies (ANA); Anti-ovarian antibodies (AOA); Anti-reticulin antibodies (RCA, ARA); Anti-skin antibodies; Anti-smooth muscle antibodies (SMA); Anti-striated muscle antibodies | ||
| Anti-glutamic acid decarboxylase antibodies (GAD); Anti-islet cell antibodies (ICA); Anti-islet cell antigen 2 antibodies; Anti-phospholipase A2 receptor antibodies (PLA2R); Anti-zinc transporter protein 8 antibodies (ZNT8) | ||
| Anti-cyclic citrullinated peptide antibodies (CCP); Anti-thyroglobulin antibodies (Tg); Anti-thyroid microsomal antibodies; Anti-zinc transporter protein 8 antibodies (ZNT8) | ||
| Anti-PML antibodies; Anti-Ro-52 antibodies; Anti-Sp-100 antibodies; Anti-glycoprotein-210 antibodies (GP210); Anti-liver antibodies; Anti-liver cytosol antibodies (LC-1); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-soluble liver antigen/liver-pancreas antibodies (SLA/LP) | ||
| Rheumatoid factor | ||
| Anti-EJ antibodies; Anti-Jo-1 antibodies; Anti-Ku antibodies; Anti-Mi-2 antibodies; Anti-NXP2 antibodies; Anti-OJ antibodies; Anti-PL-12 antibodies; Anti-PL-7 antibodies; Anti-Pm/Scl-100 antibodies; Anti-Pm/Scl-75 antibodies; Anti-Ro-52 antibodies; Anti-SAE1 antibodies; Anti-melanoma differentiation associated gene 5 antibodies (MDA5); Anti-myositis antibodies; Anti-signal recognition particle antibodies (SRP); Anti-transcription intermediary factor antibodies (TIF1) | ||
| Anti-Jo-1 antibodies; Anti-La antibodies; Anti-Pm/Scl antibodies; Anti-Pm/Scl-100 antibodies; Anti-Pm/Scl-75 antibodies; Anti-Ro-52 antibodies; Anti-Ro-60 antibodies; Anti-Scl-70 antibodies; Anti-Smith antibodies (Sm); Anti-U1 ribonucleoprotein antibodies (U1 RNP); Anti-centromere protein B antibodies (Cenp-B); Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-endomysial antibodies (EMA)Added 10/7/23. Review at next RES | ||
| Serum | Tryptase | |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens)) | Serum | Ara h2 - Peanut; Galactose-α-1,3-galactose thyroglobulin - Bovine; Ovomucoid - Egg |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Cefaclor; Chlorhexidine; Morphine; Penicilloyl G; Penicilloyl V; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Budgerigar droppings; Budgerigar feathers; Canary bird feathers; Cat epithelium; Chicken droppings; Cow dander; Dog dander; Finch feathers; Guinea pig epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Parakeet feathers; Parrot feathers; Pigeon droppings; Pigeon feathers; Rabbit epithelium; Rat epithelium; Rat serum proteins; Rat urine proteins; Sheep epithelium |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Blue mussel; Codfish; Crab; Lobster; Oyster; Salmon; Shrimp; Squid; Swordfish; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Avocado; Banana; Celery; Date; Kiwi; Mango; Onion; Orange citrus; Pineapple; Potato; Strawberry; Tomato |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Casein; Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Cacao; Coffee; Honey; Mushroom; Omega-5-gliadin; Staple food mix; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Cashew nut; Coconut; Hazelnut; Macadamia nut; Maize; Oat; Peanut; Pecan nut; Pinenut; Pistachio; Pumpkin seed; Rice; Rye; Sesame seed; Soy bean; Sunflower seed; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Grass mix; Johnson grass; Kentucky blue; Kentucky plane (June) grass; Paspalum grass; Rye grass; Timothy grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | American cockroach; German cockroach; Mosquito; Oriental cockroach |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Aspergillus flavus; Aspergillus fumigatus; Chaetomium globosum; Cladosporium herbarum; Penicillium chrysogenum (formerly Penicillium notatum); Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; House dust - Hollister-Stier |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Chlorhexidine; Latex |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Eucalyptus; Grey alder; Melaleuca; Olive; Silver birch; Tree mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Honey bee venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Plantain - English; Weed mix |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Blood; Bone marrow; Haemopoietic progenitor cells | Enumeration of CD34+ cells |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Total haemolytic complement | ||
| Complement membrane attack complex (sC5b-9); Other complement components or breakdown product | ||
| Factor H | ||
| Factor I | ||
| Factor H; Other complement components or breakdown product | ||
| Complement membrane attack complex (sC5b-9); Other complement components or breakdown product | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Albumin |
| Oligoclonal bands | ||
| Plasma; Serum | Cryoglobulins | |
| Detection and quantitation of free kappa and free lambda light chains | ||
| Serum | Detection and amount of paraproteins; Detection of Bence Jones proteins | |
| Protein classes | ||
| Urine | Protein classes | |
| Detection and amount of paraproteins; Detection of Bence Jones proteins | ||
| α1-Microglobulin | ||
| Immunopathology - Quantitative investigation and/or assessment of neutrophils | Blood | Dihydrorhodamine 123; Oxidative burst |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Cerebrospinal fluid (CSF); Urine | Total immunoglobulin G |
| Plasma; Serum | Immunoglobulin subclasses; Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | |
| Serum | Total immunoglobulin E | |
| Immunoglobulin subclasses; Total immunoglobulin D; Total immunoglobulin Gimmunoglobulin D kit changed from Abacus to Trimero July 2024. Review at next RES | ||
| Immunopathology - Single HLA antigen typing | Blood | HLA-B27 |
| Immunopathology - Tests of cellular immunity - Lymphocyte function tests | Blood; Serum | Lymphocyte function; Proliferation by antigens; Proliferation by mitogens |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Faeces | Helicobacter pylori antigen |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Helicobacter pylori IgG antibody |
| Aspergillus precipitins; Avian precipitins (bird fancier's disease); Farmer's lung precipitins |
Division of Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood | Bacteria; Pathogenic identification and antibiotic susceptibility |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; Genital swabs; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Wound swabs | Pathogenic identification and antibiotic susceptibility | |
| Aspirates; Synovial fluid | Bacteria; Crystals; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Blood | Pathogenic identification | |
| Pathogenic identification | ||
| Cerebrospinal fluid (CSF) | Streptococcus pneumoniae antigen; Pathogenic identification and antibiotic susceptibility | |
| Cerebrospinal fluid (CSF); Genital swabs; Respiratory specimens; Sputum; Superficial sites; Wound swabs | Bacteria; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Ear swabs; Eye swabs; Faeces; Genital swabs; Infection control swabs; Nasal swabs; Sputum; Urine; Wound swabs | Pathogenic identification and antibiotic susceptibility | |
| Faeces | Pathogenic identification and antibiotic susceptibility | |
| Urine | Casts; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Pathogenic identification and antibiotic susceptibility; Proteins; Specific gravity; Sugar; pH | ||
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Microbiology - Environmental investigations and/or infection control | Automated endoscope reprocessors (AER); Blood transfusion bags; Endoscopes; Vascular catheter tips | Bacterial growth - Sterility; Bacterial organism identification |
| Bacterial growth - Sterility; Bacterial organism identification | ||
| Infection control swabs | Bacterial growth - Sterility; Bacterial organism identification - Acinetobacter; Bacterial organism identification - Carbapenemase-producing Enterobacterales (CPE); Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Carbapenem resistant Enterobacteriaceae (CRE) |
| Blood | MecA gene | |
| Blood; Cerebrospinal fluid (CSF) | Neisseria meningitidis | |
| Bronchial swabs; Bronchoalveolar lavage; Cervical specimen; Dry swabs; Nasopharyngeal aspirate; Sputum | Bordetella pertussis; Mycoplasma pneumoniae | |
| Cerebrospinal fluid (CSF) | Escherichia coli K1; Haemophilus influenzae; Listeria monocytogenes; Neisseria meningitidis; Streptococcus agalactiae (Streptococcus group B); Streptococcus pneumoniae | |
| Dry swabs; Genital swabs; Liquid based cytology specimens; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Dry swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Faeces | Clostridioides difficile | |
| Campylobacter spp.; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Shiga toxin | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Cerebrospinal fluid (CSF) | Cryptococcus gattii; Cryptococcus neoformans |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium hominis; Cryptosporidium parvum; Giardia lamblia |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchoalveolar lavage; Dry swabs; Nasopharyngeal aspirate; Sputum | Adenovirus; Enterovirus; Human metapneumovirus; Human parechovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Picornavirus; Respiratory syncytial virus (RSV) A/B |
| Influenza A virus; Influenza A virus typing; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Cerebrospinal fluid (CSF) | Cytomegalovirus (CMV); Enterovirus; Human herpes virus type 6 (HHV6); Human herpes virus type 1/2 (HHV1/2); Human parechovirus; Varicella zoster virus (VZV) | |
| Dry swabs; Respiratory specimens | Cytomegalovirus (CMV); Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Herpes virus; Varicella zoster virus (VZV) | |
| Faeces | Adenovirus F40; Adenovirus F41; Norovirus G1; Norovirus G2; Rotavirus A | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Plasma | Human immunodeficiency virus type 1 (HIV-1) RNA | |
| Plasma; Serum | Hepatitis C virus (HCV) genotypes 1-6 and subtypes | |
| Hepatitis C virus (HCV) viral RNA; Hepatitis C virus (HCV) viral load - Qualitative | ||
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Bronchoalveolar lavage; Bronchoscopes; Cerebrospinal fluid (CSF); Peritoneal fluid; Pleural fluid; Pleuroscopes; Sputum; Synovial fluid; Tissues; Urine | Mycobacteria identification |
| Sputum | Mycobacteria identification | |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Blood | Fungi identification |
| Fungi identification | ||
| Bronchial lavage; Bronchial washings; Endotrachael aspirate | Fungi identification | |
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Isolates | Isolation of yeasts and Aspergillus; Yeast susceptibility; Yeasts identification | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Hepatitis C virus antibody (anti-HCV) - IgG |
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) neutralisation; Hepatitis C virus (HCV); Human immunodeficiency virus (HIV); Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma gondii IgG antibody; Toxoplasma gondii IgM antibody | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies | ||
| Human immunodeficiency virus (HIV) p24 antigen | ||
| Herpes simplex virus type 1 antibody (anti-HSV1) - IgM; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex virus type 2 antibody (anti-HSV2) - IgM; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Parvovirus IgG antibody; Parvovirus IgM antibody; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | ||
| Serum | Barmah forest virus IgG antibody; Barmah forest virus IgM antibody; Leptospira IgM antibody; Ross River virus IgG antibody; Ross River virus IgM antibody | |
| Coxiella burnetii (Q-fever) IgG phase 2 antibody | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Anti-streptolysin O (ASOT) | ||
| Syphilis Treponema pallidum antibody | ||
| Coxiella burnetii (Q-fever) IgM phase 2 antibody |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
MACU
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Neonatal Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Operating Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Paediatric Diabetes Clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Renal Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Urine | Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Red blood cell morphology |
Royal Newcastle Centre Recovery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Royal Newcastle Diabetic Clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Toxicology
ISO 15189 (2022)
Legal
Medicare expiry date
27 Jun 2027
Last Activity Date
29 Nov 2023
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Temperature; pH |
| Medico legal drug testing AS/NZS 4308:2008, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308:2008, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3561
Site No.
3554
Print date
19 Sep 2024
END OF SCOPE